Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | P82Rfs*41 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TP53 P82Rfs*41 indicates a shift in the reading frame starting at amino acid 82 and terminating 41 residues downstream causing a premature truncation of the 393 amino acid Tp53 protein (UniProt.org). P82Rfs*41 has not been biochemically characterized however, due to the effects of truncation mutations downstream of P82 (PMID: 31081129, PMID: 34045312), is predicted to lead to a loss of Tp53 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon4 TP53 P82Rfs*41 TP53 mutant TP53 inact mut TP53 P82Rfs*41 |
Transcript | NM_000546.6 |
gDNA | chr17:g.7676125delG |
cDNA | c.245delC |
Protein | p.P82Rfs*41 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000546.5 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7676125delG | c.245delC | p.P82Rfs*41 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|